SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030793
Filing Date
2024-08-08
Accepted
2024-08-08 16:27:19
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2147260
2 ex10-7.htm EX-10.7 180305
3 ex10-8.htm EX-10.8 188924
4 ex31-1.htm EX-31.1 17827
5 ex31-2.htm EX-31.2 16219
6 ex32-1.htm EX-32.1 9069
  Complete submission text file 0001493152-24-030793.txt   10960530

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ocx-20240630.xsd EX-101.SCH 57126
8 XBRL CALCULATION FILE ocx-20240630_cal.xml EX-101.CAL 78314
9 XBRL DEFINITION FILE ocx-20240630_def.xml EX-101.DEF 340750
10 XBRL LABEL FILE ocx-20240630_lab.xml EX-101.LAB 508596
11 XBRL PRESENTATION FILE ocx-20240630_pre.xml EX-101.PRE 448839
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 2130961
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 241188876
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)